PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Share News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cenkos lifts dividend after strong full-year performance

Fri, 18th Mar 2022 14:11

(Sharecast News) - Stockbroker Cenkos Securities reported an 19% improvement in revenue in its annual results on Friday, to £37.2m, as the board lifted the final dividend by more than a fifth.

The AIM-traded firm said its underlying profit grew 47% over the 12 months ended 31 December, to £5.9m, while its profit before tax jumped 75% to £4m.

Its profit after tax rocketed 88%, meanwhile, to £3.4m, while it recorded cash at year-end of £33.5m - £0.7m higher than at the end of 2020.

Net assets grew by £1.4m over the year to £27m, and the company reported basic earnings per share of 7.1p, up 91% year-on-year.

The board's paid and proposed full-year dividend was lifted 21%, to total 4.25p per share for 2021.

Looking ahead, Cenkos said the "broadly positive conditions" from 2021 were not being taken for granted, with the war in Ukraine having a "significant effect" on global economies and markets.

The lingering effects of Covid-19 on the labour market and supply chains could also impact growth and market recovery, the company warned.

Despite that macroeconomic environment, Cenkos said it remained "confident" in its business model and track record of successful fundraising at each stage of the market cycle.

It said it had started the new year well, having already completed three initial public offerings, four placings and two merger and acquisition transactions in the first 10 weeks.

"This performance was driven by an increase in transactions, with our teams completing 34 in the period, raising over £1.2bn for clients," said chief executive officer Julian Morse.

"During the year, we have added 17 new companies to our client list.

"Our investment company and trading company client base is well spread across multiple sectors and UK and other geographies."

Morse said the company supported a "diverse range" of companies in 2021, raising money on equity markets, from builders' merchants and music royalty businesses to smart fabrics and oncology diagnostics.

"With a broad pool of knowledgeable, committed investors, we partner with our clients to articulate investment cases and reduce risk in the fundraising process."

At 1315 GMT, shares in Cenkos Securities were up 17.63% at 69.99p.

More News
16 Dec 2015 12:40

DIRECTOR DEALINGS: Cenkos Chief Executive Durkin Adds To Stake

Read more
9 Dec 2015 18:00

DIRECTOR DEALINGS: Cenkos Says Durkin And Hodges Add To Holdings

Read more
8 Dec 2015 12:11

LONDON MARKET MIDDAY: Wary Eyes On BHP, Rio As Anglo Suspends Dividend

Read more
8 Dec 2015 10:40

WINNERS & LOSERS SUMMARY: Anglo American Sold As It Suspends Dividend

Read more
8 Dec 2015 09:04

Cenkos says not being investigated by SFO

(ShareCast News) - Stockbroker Cenkos Securities rallied after saying it was not being investigated by the Serious Fraud Office. The statement followed a report in the Sunday Times suggesting that the company had handed over a cache of documents to the SFO in relation to Watchstone Group, formerly k

Read more
8 Dec 2015 08:33

LONDON MARKET OPEN: Miners And Oil Firms Down As Anglo Gets "Radical"

Read more
8 Dec 2015 07:59

Cenkos Securities Says It Is Not Subject To SFO Investigation

Read more
25 Nov 2015 17:08

Cenkos To Buy Back 4.5 Million Shares Under GBP8 Million Tender Offer

Read more
30 Oct 2015 08:21

Cenkos Gets Started On GBP8.0 Million Return To Shareholders

Read more
22 Sep 2015 08:47

Cenkos Securities Profit Down On Lower AIM Activity In First Half

Read more
26 Jun 2015 10:34

Essenden Agrees To GBP40.1 Million Takeover Offer From Harwood Capital

Read more
15 Jun 2015 16:45

U.S. biotech company Evofem eyes London listing -sources

LONDON, June 15 (Reuters) - Biotech company Evofem is working with U.S. bank JP Morgan and British broker Cenkos on a London stock market listing aimed at raising about $200 million, three sources familiar with the matter said on Monday. San Diego-based Evofem, which specialises in women's

Read more
12 May 2015 08:25

Cenkos Securities Chairman Says Pipeline Remains Encouraging

Read more
7 May 2015 09:48

Verseon, Curtis Banks And MayAir Début On AIM (ALLIPO)

Read more
1 May 2015 11:28

DIRECTOR DEALINGS SUMMARY: Sweett Group Directors Buy 232,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.